title: [Neoadjuvant treatment for unresectable pancreatic tumors: Against!].
abstract: Should we consider surgery for pancreatic cancer when resectability seems initially uncertain? The answer is no consensual as illustrated by the controversy presented here. This article presents the key arguments against surgery.
authors.affiliation: Groupe digestif, Institut Bergonié, Université de Bordeaux, Inserm Unité 1029, Bordeaux, France. Electronic address: S.Evrard@bordeaux.unicancer.fr.
authors.forename: Serge
authors.initials: S
authors.lastname: Évrard
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D058990:Molecular Targeted Therapy; D020360:Neoadjuvant Therapy; D010190:Pancreatic Neoplasms / Q000235:genetics / Q000473:pathology / Q000601:surgery* / Q000628:therapy
chemical_list: D000970:Antineoplastic Agents
keywords: Cancer du pancréas; Chirurgie; Neoadjuvant treatments; Pancreatic cancer; Surgery; Traitements néo-adjuvants